In this study, we investigated the function and mechanism of METTL3 in the pathogenesis of RB and revealed that METTL3 promotes RB progression in vitro and in vivo, suggesting that METTL3 may be a novel therapeutic target for RB treatment. Here, METTL3 is linked to retinoblastoma.